Don C. Rockey  Clinical Gastroenterology and Hepatology 

Slides:



Advertisements
Similar presentations
Don C. Rockey  Clinical Gastroenterology and Hepatology 
Advertisements

Abnormal Liver Tests and Fatty Liver on Ultrasound
Thrombocytopenia With Abnormal Liver Function Tests
Incorrect Calculation and Inappropriate Interpretation: Accuracy of International Guidelines for Identifying Significant Fibrosis in e Antigen–Negative.
The inflammasome in liver disease
Inflammation and Colon Cancer
Millie D. Long, Bruce E. Sands 
Gauree Gupta, Ebbing Lautenbach, James D. Lewis 
Is HCV Infection a Neurologic Disorder?
Pathogenesis of primary biliary cirrhosis
Roles for Chemokines in Liver Disease
Senescence: Not Just for Tumor Suppression
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Liver Renewal: Detecting Misrepair and Optimizing Regeneration
A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus  Amit G. Singal, Michael.
Mechanisms of Hepatic Fibrogenesis
Desmoplasia of Pancreatic Ductal Adenocarcinoma
Liver Cirrhosis Is Associated With Venous Thromboembolism Among Hospitalized Patients in a Nationwide US Study  Harry Wu, Geoffrey C. Nguyen  Clinical.
Volume 138, Issue 4, Pages (April 2010)
Stephen A. Harrison, MD, FACP  Clinical Gastroenterology and Hepatology 
Volume 66, Issue 2, Pages (February 2017)
From immunosuppression to tolerance
Hepatitis C and Lymphoproliferative Disorders: From Mixed Cryoglobulinemia to Non- Hodgkin's Lymphoma  Lenna A. Martyak, Melina Yeganeh, Sammy Saab  Clinical.
Issue Highlights Clinical Gastroenterology and Hepatology
Signalling pathways in alcohol-induced liver inflammation
Targeting gut flora to prevent progression of hepatocellular carcinoma
Gaps in Knowledge and Research Priorities for Alcoholic Hepatitis
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Interpreting Hepatitis B Surface Antigen Levels: Useful Clinical Test or Just Another Confusing Assay?  Brian J. McMahon, MD, Brenna C. Simons, PhD  Clinical.
Autophagy and senescence in fibrosing cholangiopathies
Nitin Raj, Laura D. Attardi  Current Biology 
The Genetics of Inflammatory Bowel Disease
Volume 146, Issue 5, Pages (May 2014)
Viral Hepatitis in Liver Transplantation
Approaches for treatment of liver fibrosis in chronic hepatitis C
Endoscopic Therapy for Barrett's Esophagus
Amie L. Harvey, Tommy Yen, Anand Kunda 
Metastatic Malignant Melanoma of the Gastrointestinal Tract
Abnormal Liver Tests and Fatty Liver on Ultrasound
Veronika Lukacs-Kornek, Detlef Schuppan  Journal of Hepatology 
YAPping About Glutaminolysis in Hepatic Fibrosis
Volume 70, Issue 7, Pages (October 2006)
Volume 144, Issue 3, Pages (March 2013)
Volume 146, Issue 4, Pages e1 (April 2014)
Herbert Tilg, Gökhan S. Hotamisligil  Gastroenterology 
Antifibrotic therapy in chronic liver disease
A New Treatment for Portal Hypertension?
Volume 61, Issue 1, Pages S79-S90 (November 2014)
Volume 123, Issue 6, Pages (December 2002)
Pathogenesis of primary biliary cirrhosis
Alan Bonder, MD, Nezam H. Afdhal, MD 
Volume 142, Issue 4, Pages e6 (April 2012)
Macrophage heterogeneity in liver injury and fibrosis
Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet 
The dynamic biliary epithelia: Molecules, pathways, and disease
Hepatic Cyst? Clinical Gastroenterology and Hepatology
Thrombocytopenia With Abnormal Liver Function Tests
Silvia Affò, Ramón Bataller  Journal of Hepatology 
Volume 132, Issue 5, Pages (May 2007)
Tatiana Kisseleva, David A. Brenner  Journal of Hepatology 
Tetsuo Takehara, Norio Hayashi 
Volume 134, Issue 1, Pages 8-14 (January 2008)
Coagulation in Liver Disease: A Guide for the Clinician
Controversies in the management of hepatitis C patients with advanced fibrosis and cirrhosis  Robert J Fontana, Gregory T Everson, Sony Tuteja, Hugo E.
Issue Highlights Clinical Gastroenterology and Hepatology
Foxa1 and Foxa2 regulate bile duct development in mice
Sander Lefere, Frank Tacke  JHEP Reports 
Ajaypal Singh, John D. Christein, Shyam Varadarajulu 
Sanjay K. Murthy, E. Jenny Heathcote, Geoffrey C. Nguyen 
Metastatic Malignant Melanoma of the Gastrointestinal Tract
Presentation transcript:

Translating an Understanding of the Pathogenesis of Hepatic Fibrosis to Novel Therapies  Don C. Rockey  Clinical Gastroenterology and Hepatology  Volume 11, Issue 3, Pages 224-231.e5 (March 2013) DOI: 10.1016/j.cgh.2013.01.005 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 Liver injury and fibrogenesis. In the liver, many different types of injuries (ie, chronic hepatitis, ethanol, metabolic disease, biliary tract disease, iron, copper, and so forth) lead to hepatocyte injury, and then typically an inflammatory response. This injury process is complicated, but in aggregate it stimulates a wound healing response, which involves a number of different systems. Paramount in this process often is the recruitment of inflammatory cells. Among other properties, inflammatory cells produce a variety of mediators, cytokines, and other factors, which in turn are responsible for stimulation and/or recruitment of other cells. Key among these other cells include effector cells, highlighted in the figure, and including stellate cells, fibrocytes, fibroblasts, and even fibroblasts derived through epithelial to mesenchymal transition. These effectors produce extracellular matrix proteins (see text) and importantly interact with other cells in the wounding milieu. In addition, it is important to emphasize that many forms of injury lead to activation and transformation of other cells in the liver, such as endothelial and bile duct epithelial cells. Injury to these cells in turn leads to a variety of downstream effects. Each injured endothelial bile duct epithelial cell is capable of stimulating effector cells to produce extracellular matrix constituents. LPS, lipopolysaccharide; NK, natural killer. Clinical Gastroenterology and Hepatology 2013 11, 224-231.e5DOI: (10.1016/j.cgh.2013.01.005) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 Stellate cell activation. A key pathogenic feature underlying liver fibrosis and cirrhosis is activation of hepatic stellate cells (note that activation of other effector cells is likely to parallel that of stellate cells). The activation process is complex, both in terms of the events that induce activation and the effects of activation. Multiple and varied stimuli participate in the induction and maintenance of activation, including but not limited to cytokines, peptides, and the extracellular matrix itself. Recently, signaling through Toll-like receptor (TLR)4 on stellate cells has been identified as important in activation. Key phenotypic features of activation include production of extracellular matrix, loss of retinoids, proliferation, up-regulation of smooth muscle proteins, secretion of peptides and cytokines (which have autocrine effects on stellate cells and paracrine effects on other cells such as leukocytes and malignant cells), and up-regulation of various cytokine and peptide receptors. In addition, evidence indicates that stellate cells show several cell fates, highlighted at the bottom of the figure, and each of these appear to play a role in the biology of fibrogenesis. Clinical Gastroenterology and Hepatology 2013 11, 224-231.e5DOI: (10.1016/j.cgh.2013.01.005) Copyright © 2013 AGA Institute Terms and Conditions